Intelligence Β· Patent portfolio
Disc Medicine Patents
Full USPTO pharma patent portfolio for Disc Medicine β grant dates, expiration, and drug cross-links.
- Patents
- 706
- Expiring β€24m
- 26
Quick answer
Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months β use filters for patent-cliff planning.
-
US 6376654
Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
expired -
US 6372723
Compositions and methods for preventing restenosis following revascularization procedures
expired -
US 6353010
Bicyclic aryl carboxamides and their therapeutic use
expired -
US 6339072
Compositions and methods for preventing restenosis following revascularization procedures
expired -
US 6331556
Heterocyclic compounds and their therapeutic use
expired -
US 6313116
Benzothiazole compounds and their therapeutic use
expired -
US 6310088
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
expired -
US 6297004
Recombinant viruses displaying a nonviral polypeptide on their external surface
expired -
US 6297286
Therapeutic use and formulation
expired -
US 6284805
Plastics container containing stabilized drug formulation
expired -
US 6277827
Single morphic forms of metalloproteinase inhibitors
expired -
US 6270761
Delivery of nucleic acid
expired -
US 6267980
Dosage forms and uses
expired -
US 6221394
Dosage forms
expired -
US 6214991
Substituted indolealkanoic acids
expired -
US 6197811
Cytokine production inhibitors
expired -
US 6191147
Pyrazole compounds and uses thereof
expired -
US 6180611
Peptidyl compounds
expired -
US 6169090
Heterocyclic compounds and their therapeutic use
expired -
US 6133240
Tetrahydronapthalene derivatives and their therapeutic use
expired -
US 6124288
Xanthines and their therapeutic use
expired -
US 6118001
Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
expired -
US 6114372
Peptidyl compounds having MMP and TNF inhibitory activity
expired -
US 6110896
Peptidyl compounds and their therapeutic use
expired -
US 6103741
Analgesic agent and its use
expired -
US 6100266
Hydroxamic and carboxylic acid derivatives
expired -
US 6090840
Peptidyl compounds having MMP and TNF inhibitory activity
expired -
US 6071497
Microparticles for lung delivery comprising diketopiperazine
expired -
US 6069155
Levobupivacaine and its use
expired -
US 6069151
Quinolines and their therapeutic use
expired -
US 6066657
Benzofuran-4-carboxamides and their therapeutic use
expired -
US 6056968
Pharmaceutical drug dosage forms providing different release rates
expired -
US 6048841
Peptidyl compounds
expired -
US 6037337
Use of the enantiomers of ifosfamide in antitumor therapy for reducing side effects
expired
Frequently asked questions
How many patents does Disc Medicine have?
706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Disc Medicine patents expire?
26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory